Mengsen Li
Impact in
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism
- MicroRNA in disease regulation
Papers in
-
- Epigenetics and DNA Methylation 11
- Cell death mechanisms and regulation 5
- Renal and related cancers 4
- PI3K/AKT/mTOR signaling in cancer 4
- Oncology 15
- Pancreatic and Hepatic Oncology Research 7
- Co-authors
- Mingyue Zhu (38 shared papers)Bo Lin (24 shared papers)Wei Li (16 shared papers)Junli Guo (14 shared papers)Yan Lu (17 shared papers)Yi Chen (10 shared papers)Xinhua Liu (7 shared papers)Xieju Xie (8 shared papers)
- Journals
- Journal of Cellular and Molecular Medicine (5 papers)Frontiers in Oncology (4 papers)International Journal of Cancer (4 papers)Cancer Letters (3 papers)Oncotarget (3 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Mengsen Li
61 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 104
- Hepatology 463
- Cancer Research 362
- Oncology 417
- Structural Biology 19
- Immunology 236
Countries citing papers authored by Mengsen Li
This map shows the geographic impact of Mengsen Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengsen Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengsen Li more than expected).
Fields of papers citing papers by Mengsen Li
This network shows the impact of papers produced by Mengsen Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengsen Li. The network helps show where Mengsen Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Mengsen Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 161 | |
| 2 | 2020 | 127 | |
| 3 | 2016 | 112 | |
| 4 | 2010 | 109 | |
| 5 | 2002 | 101 | |
| 6 | 2019 | 100 | |
| 7 | 2018 | 96 | |
| 8 | 2016 | 79 | |
| 9 | 2009 | 75 | |
| 10 | 2015 | 62 | |
| 11 | 2009 | 60 | |
| 12 | 2023 | 57 | |
| 13 | 2005 | 49 | |
| 14 | 2004 | 46 | |
| 15 | 2015 | 46 | |
| 16 | 2022 | 44 | |
| 17 | 2005 | 40 | |
| 18 | 2014 | 39 | |
| 19 | 2017 | 39 | |
| 20 | 2017 | 38 |
About Mengsen Li
Mengsen Li is a scholar working on Molecular Biology, Oncology, Immunology, Cancer Research and Epidemiology, having authored 64 papers that have together received 2.1k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Pancreatic and Hepatic Oncology Research (7 papers), Hepatitis B Virus Studies (6 papers), Cell death mechanisms and regulation (5 papers), Cancer, Lipids, and Metabolism (5 papers), Renal and related cancers (4 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). The work is most often cited by research in Hepatology (463 citations), Cancer Research (362 citations), Oncology (417 citations), Structural Biology (19 citations) and Immunology (236 citations). Mengsen Li has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Mingyue Zhu, Bo Lin, Wei Li, Junli Guo, Yan Lu, Yi Chen, Xinhua Liu, Xieju Xie, Sheng Zhou and Haifeng Lin. Their work appears in journals such as Journal of Cellular and Molecular Medicine, Frontiers in Oncology, International Journal of Cancer, Cancer Letters and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.